Judy George is a Senior Staff Writer for MedPage Today and Knowledia. With a background in medical journalism, Judy covers a wide range of health topics, including dementia, chronic pain, Alzheimer's disease, and the latest advancements in medical research and treatments. Her work has also been featured on ABC Network News.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Judy George's coverage mainly focuses on healthcare, pharmaceuticals, and scientific research. She frequently cites data and reports on government announcements related to health topics. Therefore, she is likely to be responsive to pitches that offer access to new or exclusive data in the healthcare and pharmaceutical sector. Additionally, Judy may be interested in expert analysis or commentary on recent government announcements concerning health-related issues.
Given her extensive coverage of neurological conditions such as dementia and chronic pain, sources with expertise in these areas are likely to appeal to her. If you have insights into innovative treatments or emerging trends within the healthcare industry, particularly those related to neurology or chronic pain management, Judy would likely find them valuable for her reporting.
This information evolves through artificial intelligence and human feedback. Improve this profile .
— Contrast sensitivity impairment showed the strongest relationship Key Takeaways
— Mucosal damage seen on upper endoscopy associated with 76% higher Parkinson's risk Key Takeaways
— Regulatory, policy requirements not met in Havana syndrome study, agency says
By: Judy George
— News and commentary from the world of neurology and neuroscience
In his new book, Theodore Schwartz, MD, immerses readers in the story of brain surgery
— Findings suggest a pathway for plastic fragments to enter the brain Key Takeaways
By: Judy George
— News and commentary from the world of neurology and neuroscience
By: Judy George
— Analysis looks at pooled data of 17,000 MS trial participants Higher comorbidity burden among people with multiple sclerosis (MS) was associated with worse clinical outcomes, pooled trial data showed.
By: Judy George
— Triptans are efficacious and underused, researchers say Key Takeaways
— Patients with high NfL at disease onset may benefit from high-efficacy treatments
(833) 317-6278 
